Min Wan

Yesterday was one of those moments that reminds you how far #Baltimore’s #lifescience ecosystem has come — and where it’s headed next. 🚀 Huge congratulations to Blackbird Laboratories, Matt Tremblay, Ph.D. and the entire team on the opening of the #BlackbirdBioHub and celebrating three years since launching their venture platform. Full BioBuzz Article in comments below 👇 📈 What started as an ambitious effort to fund bold science and build companies in Baltimore has now evolved into something even bigger: a physical hub with cutting edge lab facilities and a space designed to bring together founders, scientists, investors, and partners who are shaping the future of biotech in our city. ✨ Walking through the new #BioHub, the intent behind the space is clear. Bright, open labs and offices. Collaborative workspaces. Gathering areas built for town halls, fireside chats, and community events. It’s designed for one thing: bringing innovators together to thrive. 🧬 A few of the startups helping activate the BioHub include: 🔬 #EPOCHEpigenetics (Eric Van Gieson) – developing next-generation diagnostic technology that analyzes epigenetic signals in immune cells to detect disease earlier and more accurately. 🧬 Aletira Therapeutics – a gene therapy startup spun out of Johns Hopkins University developing technologies that allow precise control of therapeutic gene expression to improve safety and efficacy. The Biohub sits right inside what is quickly becoming one of the most vibrant life science micro-ecosystems in Maryland (or possibly in the MidAtlantic) — #CityGarage. Today, startups launching there have access to something rare in a single location: • Medtech acceleration support through The LaunchPort, that includes contract manufacturing capabilities with on-site cleanroom facilities • The new Blackbird BioHub supporting therapeutics startups and venture-backed company creation • A new #vivarium operated by MYOLOGICA, LLC, enabling local preclinical research 🐁 • Device prototyping support through RPM Tech (Rapid Prototyping and Manufacturing Technologies, LLC) • Talent and staffing solutions through Workforce Genetics 🤝 • Connectivity and a national platform to amplify innovators and their stories through BioBuzz 🐝 And importantly, City Garage is now home to 3 #venture firms helping fuel the next generation of companies 💰 • Blackbird Ventures • PTX Capital (Matt Hellauer) • A Capital (Deborah Hemingway, PhD) That kind of end-to-end support — from early discovery and prototyping to talent, funding, and commercialization — is exactly what strong biotech ecosystems need to thrive. In just three years Blackbird has already deployed significant capital, supported dozens of research projects, and helped launch multiple companies rooted right here in Maryland. Excited to see what new companies will launch from this space in the years ahead. #Baltimore #Biotech #LifeSciences #StartupEcosystem #BioHealthCapitalRegion

324

10 Comments

🧶 Looking to unravel your epigenetics research with Fiber-seq? PacBio’s 2025 Epigenetics SMRT Grant Program is now open! Enter now for a chance to win FREE Fiber-seq sequencing and library prep. Fiber-seq is a game-changing multiomic platform that captures both genomic and epigenomic information in a single long-read sequencing experiment. It simultaneously profiles chromatin accessibility, DNA methylation, protein footprints, and genetic variants, delivering a complete picture of chromatin architecture at single-molecule resolution. EpiCypher is proud to support this grant program and help bring cutting-edge epigenomics to more researchers worldwide. 🔬 Apply here: https://lnkd.in/eaPjMiRZ 🔗 Learn more about CUTANA™ Fiber-seq here: https://lnkd.in/ee5GiqhU

18

After over 25 years in the gene therapy/gene editing field, I have never been more optimistic about how these technologies are going to transform patients lives. I really appreciate Ryan Cross for highlighting the importance of programmable gene insertion (PGI) as one of the missing tools in the gene editing toolbox and how it is poised to play a transformative role in the medical field. The rapid advances in AI and an evolving regulatory landscape have set the stage for addressing one of the key issues that Ryan raises in the article: not enough cures are coming out the other side. At Basecamp Research, we are focusing on applying our unique combination of evolutionary data and foundation AI models to address this issue. Watch this space....

174

2 Comments